Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein. - Wikidata - wikimedia - TriplyDB

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.

http://www.wikidata.org/entity/Q37630372

about

Murine Cytomegalovirus Spreads by Dendritic Cell Recirculation Immunosenescence in persons with spinal cord injury in relation to urinary tract infections -a cross-sectional study.Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection.Human Cytomegalovirus Encodes a Novel FLT3 Receptor Ligand Necessary for Hematopoietic Cell Differentiation and Viral Reactivation.The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth.Navigating the Host Cell Response during Entry into Sites of Latent Cytomegalovirus Infection.Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing.Cytomegalovirus infection and progressive differentiation of effector-memory T cells US28: HCMV's Swiss Army Knife

P2860

Q41898746-60916332-7D12-4454-AABF-DADEA86FF092 Q47108782-B9FBAE3C-F64E-4CFA-8B66-F091C81808A1 Q47147600-1FB12895-75FF-418C-9ED0-471BD6AF6EE2 Q52565522-CD6536A4-299B-4B2C-BEEA-1CE545923B24 Q52715827-B7562E01-1253-4860-8658-9B27FBE5137F Q54254744-BE45FD29-5918-4326-8667-B15829309D84 Q55032738-6FEC3A57-84E9-4B1A-B3F6-A2159216E709 Q57821275-55CD499B-866C-4C3B-AA7F-5100088F9453 Q58734495-9DC30010-3F7B-4703-9970-45F66F7E5C6A

P2860

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.

http://www.wikidata.org/entity/Q37630372

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.

@en

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.

@nl

type

label

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.

@en

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.

@nl

prefLabel

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.

@en

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein.

@nl

P1433

Q37630372-F3D61EF8-D2D4-4B76-BC7F-50391C4EDB7A

P1476

Q37630372-ABBB21BF-93A3-44E3-B1E6-AD2C97399C1D

P2093

Q37630372-620CFC55-22C5-42AC-B6A3-F6308B07BFE3

Q37630372-6B19802B-9C1B-4636-8D6A-EED6B10E953D

Q37630372-72DC740C-5C04-4FCD-92DB-6DE5B55DDA25

Q37630372-E777B17E-7842-47DC-A8F0-279AE711644D

P2860

Q37630372-004FCAC9-A22B-45BA-8DB7-856D6D221F37

Q37630372-033EA31F-F019-49F9-8407-6B3DA5046627

Q37630372-0817FD65-9979-4D3A-885D-81244C46D06E

Q37630372-0AEB80D0-093E-4142-88DA-4964C59E3146

Q37630372-0C9419E6-B3B2-4E16-BE02-49AA83641E7D

Q37630372-14471C5A-BB03-4E7F-BB69-288343DCF5D9

Q37630372-1831A377-B4CE-4364-B7C3-5C62AA5E8EBB

Q37630372-24C6E70D-8AE4-4EE5-830D-4376B6BB6C24

Q37630372-265566AA-FE64-471D-8233-59D487170072

Q37630372-32846F64-B919-49BB-96AA-BB11B4AB3761

P2888

Q37630372-6D04681E-672D-478B-9FCF-19C8D08C3777

P304

Q37630372-C57EDA0F-2102-45CB-AE21-84E296D7409F

P31

Q37630372-8F30611B-8A74-4B5F-AC82-F4E6A0980ED4

P356

Q37630372-428ECAE8-52DB-4CC5-8784-554C1D2AFD01

P407

Q37630372-99BD7D8E-CB14-4AFF-A00E-94B5216C3F66

P478

Q37630372-1132E9E5-5744-4425-A2CD-DB23F5338246

P50

Q37630372-2FFA8A64-0BE3-4344-8B60-6AE1FB589ECB

Q37630372-3A98DEAA-1BE2-4F44-AFFA-DDE051B87E88

Q37630372-6310C73F-24DA-43BC-BD23-15BD5BB7B25D

Q37630372-C41CAB66-CE66-4B08-A889-5D6BFA4B8B8B

P577

Q37630372-572AF379-E203-42F7-BB8D-4CBB4D81B772

P698

Q37630372-C69BA161-21D0-4AF4-AA46-AC5C0895FC79

P921

Q37630372-066912D3-534F-4731-9E9C-A423E528F0A8

P932

Q37630372-C3ADB4E6-EFA3-4203-92A7-EA08BB8FC8DB

P356

P1433

Nature Communications

P1476

Targeting the latent cytomegalovirus reservoir with an antiviral fusion toxin protein

@en

P2093

B A Krishna

http://www.w3.org/2001/XMLSchema#string

E L Poole

http://www.w3.org/2001/XMLSchema#string

J H Sinclair

http://www.w3.org/2001/XMLSchema#string

T N Kledal

http://www.w3.org/2001/XMLSchema#string

P2860

Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes.

Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent

Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers.

Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.

Experimental human cytomegalovirus latency in CD14+ monocytes.

Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency.

HCMV protein LUNA is required for viral reactivation from latently infected primary CD14⁺ cells.

Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14 (+) monocytes and CD34 (+) cells.

Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis.

Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation.

P2888

P304

14321

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCOMMS14321

http://www.w3.org/2001/XMLSchema#string

P407

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Mette M. Rosenkilde

Sebastian Voigt

P577

2017-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28148951

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

5296658

http://www.w3.org/2001/XMLSchema#string